Gastroenterology

Gastroenterology

Volume 94, Issue 3, March 1988, Pages 611-621
Gastroenterology

Stress-induced changes in intestinal transit in the rat: A model for irritable bowel syndrome

https://doi.org/10.1016/0016-5085(88)90231-4Get rights and content

Abstract

Stress in humans commonly results in gastrointestinal dysfunction, which is characterized by its symptomatology because the etiology is completely unknown. We developed an animal model in which to study the effects of stress on the gastrointestinal tract, and characterized the model as a stressor by evaluating endocrine and analgesic responses to mild restraint. Mild restraint (wrap restraint) elevated plasma levels of adrenocorticotropic hormone and β-endorphin, and caused analgesia. The different regions of the gastrointestinal tract responded differently to the stress stimulus. Gastric emptying was not affected, small intestinal transit was inhibited, and large intestinal transit was stimulated by stress, and there was an associated increase in fecal excretion. Wrap-restraint stress did not result in the formation of ulcers. There was a strong correlation between stress-induced adrenocorticotropic hormone release and stress-induced intestinal dysfunction over a 24-h period that suggested a circadian influence. However, neither exogenous adrenocorticotropic hormone nor β-endorphin had any effect on intestinal transit. Furthermore, neither adrenalectomy nor hypophysectomy prevented the response of the intestine to stress, suggesting that neither adrenal nor pituitary-derived factors are responsible for mediating the effects of stress on the gut. We conclude that wrap-restraint stress produces different effects on different regions of the intestine, suggesting that the small and large intestines are independently regulated and can respond differently to different stimuli. There were similarities between the intestinal effects of wraprestraint stress in rats and intestinal symptoms associated with stress and irritable bowel syndrome in humans. Therefore, wrap restraint may be an appropriate animal model in which to study stress-related intestinal dysfunction. The mechanisms by which stress affects intestinal transit are still unresolved; however, the intestinal effects of stress are not mediated by either pituitary or adrenally derived factors.

References (29)

  • CL Williams et al.

    Stress, opioids, and gastrointestinal transit

  • DA Fox et al.

    Surfactants selectively ablate enteric neurons of the rat jejunum

    J Pharmacol Exp Ther

    (1983)
  • FE D'Amour et al.

    A method for determining loss of pain sensation

    J Pharmacol Exp Ther

    (1941)
  • RJ Tallorida et al.
  • Cited by (244)

    • Paeoniflorin alleviates inflammatory response in IBS-D mouse model via downregulation of the NLRP3 inflammasome pathway with involvement of miR-29a

      2022, Heliyon
      Citation Excerpt :

      Six-to-eight-week-old male mice weighing 20–25 g were selected for this study. The IBS-D model was established in mice as previously reported, with certain adjustments [20, 29]. Briefly, mice were anesthetized with ether, their colons were instilled with 0.1 mL TNBS dissolved in 50% ethanol (50 mg/mL) 2 cm from the anus, and mice were held upside down for 30 s to prevent TNBS from leaking out.

    • Neuroinflammatory remodeling of the anterior cingulate cortex as a key driver of mood disorders in gastrointestinal disease and disorders

      2022, Neuroscience and Biobehavioral Reviews
      Citation Excerpt :

      The weight of evidence supports an association between psychosocial stress and clinical relapse in IBD (Martin et al., 2015), and exacerbation of IBS (Qin et al., 2014; O’Malley et al., 2011). Animal studies reveal that stress can induce dysfunction in the epithelial barrier, (Lennon et al., 2013; Øines et al., 2012; Cameron and Perdue, 2005; Chen et al., 2017), alter gastrointestinal motility (Williams et al., 1988; Larauche et al., 2009), influence visceral pain (Greenwood-Van Meerveld and Johnson, 2017), and aggravate colitic disease (Lennon et al., 2013; Reber et al., 2006; Deng et al., 2016; Çetinel et al., 2010; Gue et al., 1997; Koh et al., 2015a; Mackos et al., 2016; Matsunaga et al., 2011; Reber et al., 2008; Schultz et al., 2015; Veenema et al., 2008; Xu et al., 2008). For instance, colitis alters stress responses (Reichmann et al., 2015, 2013; Kresse et al., 2001), and both stress and depression can reactivate colitis (Ghia et al., 2009; Qiu et al., 1999).

    View all citing articles on Scopus

    This work was supported by grants DA02163 and DK36289 from the U.S. Public Health Service.

    View full text